Behnes, M., Bertsch, T., Lepiorz, D., Lang, S., Trinkmann, F., Brueckmann, M., . . . Hoffmann, U. (2014). Diagnostic and prognostic utility of soluble CD 14 subtype (presepsin) for severe sepsis and septic shock during the first week of intensive care treatment. BioMed Central.

Behnes, Michael, Thomas Bertsch, Dominic Lepiorz, Siegfried Lang, Frederik Trinkmann, Martina Brueckmann, Martin Borggrefe, och Ursula Hoffmann. Diagnostic and Prognostic Utility of Soluble CD 14 Subtype (presepsin) for Severe Sepsis and Septic Shock During the First Week of Intensive Care Treatment. BioMed Central, 2014.

Behnes, Michael, et al. Diagnostic and Prognostic Utility of Soluble CD 14 Subtype (presepsin) for Severe Sepsis and Septic Shock During the First Week of Intensive Care Treatment. BioMed Central, 2014.